4/17/24 12:04 | 4/17/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | 3 | P | 320 | 14.23 | 0 | 23 | 95 | 46 | D | | | | | | | | | | | | | | |
4/15/24 19:21 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | 2 | P.d | 15,152 | 0.5180 | 0 | 29,248 | 41 | 100,366 | M | | | | | | | | | | | | | | |
4/15/24 06:04 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggs Josh | CA | DO | CEO,P | 1 | P | 10 | 2.95 | 0 | 3 | 999% | 4 | D | | | | | | | | | | | | | | |
4/15/24 06:02 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | 2 | P | 188 | 0.6618 | 0 | 284 | 102 | 562 | D | | | | | | | | | | | | | | |
4/11/24 11:40 | 4/11/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | DE | D | | 1 | P | 98 | 13.06 | 0 | 8 | 54 | 21 | D | | | | | | | | | | | | | | |
4/10/24 16:18 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | 2 | P | 307 | 13.63 | 0 | 23 | 298 | 30 | D | | | | | | | | | | | | | | |
4/10/24 14:25 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | 1 | P | 284 | 12.36 | 0 | 23 | 18 | 152 | D | | | | | | | | | | | | | | |
3/8/24 11:24 | 3/6/24 | CATX | Perspective Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lantheus Alpha Therapy, LLC | MA | T | | 1 | P | 57,409 | 0.9500 | 0 | 60,431 | 107 | 116,773 | D | | | | | | | | | | | | | | |
3/6/24 16:49 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | 1 | P.d | 46 | 4.59 | 0 | 10 | 35 | 39 | D | | | | | | | | | | | | | | |
3/6/24 16:43 | 5/30/23 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | 2 | P.d | 73 | 4.89 | 0 | 15 | 24 | 77 | D | | | | | | | | | | | | | | |
2/27/24 16:21 | 8/15/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Grossman Paul David | CA | D | | 1 | P.m | 50 | 5.37 | 0 | 9 | | 9 | D | | | | | | | | | | | | | | |
2/26/24 18:48 | 2/23/24 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Busky Joseph M | CA | O | CFO | 1 | P | 100 | 46.35 | 0 | 2 | 54 | 6 | I | | | | | | | | | | | | | | |
1/30/24 20:31 | 1/26/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | 3 | P.d | 67 | 3.35 | 0 | 20 | 17 | 135 | D | | | | | | | | | | | | | | |
12/19/23 10:59 | 12/18/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | 5 | P | 50 | 1.04 | 0 | 48 | 21 | 278 | D | | | | | | | | | | | | | | |
12/14/23 09:11 | 12/13/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rootsaert Rodney Gerard | NV | O | Secretar | 1 | P | 6 | 0.6000 | 0 | 10 | 1 | 1,086 | D | | | | | | | | | | | | | | |
12/11/23 08:51 | 12/8/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | 2 | P | 19 | 0.9450 | 0 | 20 | 1 | 2,746 | D | | | | | | | | | | | | | | |
12/1/23 17:44 | 11/30/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gelhaus Ken | CA | O | Chief Co | 2 | P | 13 | 1.70 | 0 | 8 | 49 | 23 | D | | | | | | | | | | | | | | |
11/28/23 09:39 | 11/27/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | 4 | P | 447 | 1.57 | 0 | 284 | 12 | 2,601 | D | | | | | | | | | | | | | | |
11/28/23 09:39 | 11/27/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Futcher Edward | NV | D | | 2 | P | 13 | 0.9500 | 0 | 14 | 3 | 428 | D | | | | | | | | | | | | | | |
11/3/23 13:59 | 11/3/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | 1 | P | 32 | 16.06 | 0 | 2 | 8 | 27 | D | | | | | | | | | | | | | | |
10/12/23 16:01 | 10/12/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | 1 | P | 46 | 15.19 | 0 | 3 | 17 | 20 | D | | | | | | | | | | | | | | |
9/21/23 20:58 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Telegraph Hill Partners Iv, L.P. | CA | T | | 1 | P | 15,000 | 1.85 | 0 | 8,108 | 46 | 25,621 | M | | | | | | | | | | | | | | |
9/21/23 17:04 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrill Damon | CA | O | GC,CCO | 1 | P | 50 | 1.85 | 0 | 27 | 193 | 41 | D | | | | | | | | | | | | | | |
9/21/23 17:04 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mackowski J Matthew | CA | D | | 1 | P | 1,500 | 1.85 | 0 | 811 | 999% | 821 | I | | | | | | | | | | | | | | |
9/21/23 17:03 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lowell Matthew | CA | O | CFO | 1 | P | 100 | 1.85 | 0 | 54 | 159 | 88 | D | | | | | | | | | | | | | | |
9/21/23 17:03 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gunstream Stephen | CA | DO | P,CEO | 2 | P | 108 | 1.84 | 0 | 59 | 56 | 163 | D | | | | | | | | | | | | | | |
9/19/23 16:05 | 8/31/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Henshall Mickie | NV | D | | 1 | P | 5 | 1.25 | 0 | 4 | 25 | 19 | D | | | | | | | | | | | | | | |
9/12/23 18:37 | 9/8/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hombeck Torsten | TX | O | CFO | 2 | P | 13 | 4.22 | 0 | 3 | | 3 | D | | | | | | | | | | | | | | |
9/8/23 12:18 | 8/25/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DOT | CEO | 1 | P.m | 10 | 0.5459 | 0 | 18 | 17 | 128 | I | | | | | | | | | | | | | | |
9/8/23 12:12 | 8/25/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | 1 | P.m | 10 | 0.5459 | 0 | 18 | 17 | 128 | D | | | | | | | | | | | | | | |
9/6/23 10:01 | 9/5/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Barnes Phillip | NV | D | | 1 | P | 7 | 1.30 | 0 | 5 | 25 | 25 | D | | | | | | | | | | | | | | |
9/5/23 16:14 | 8/24/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Philibert Robert | IL | DOT | Chief Me | 1 | P.m | 20 | 0.5999 | 0 | 34 | 1 | 3,282 | I | | | | | | | | | | | | | | |
9/1/23 09:41 | 8/31/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | NV | D | | 1 | P | 12 | 1.28 | 0 | 10 | 0 | 2,030 | D | | | | | | | | | | | | | | |
8/31/23 09:35 | 8/29/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | 2 | P.m | 50 | 1.25 | 0 | 40 | 14 | 328 | I | | | | | | | | | | | | | | |
8/25/23 11:49 | 8/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Kway Jasmine | NV | O | CEO - Si | 1 | P | 6 | 1.20 | 0 | 5 | 6 | 87 | I | | | | | | | | | | | | | | |
8/24/23 17:58 | 8/24/23 | MYMD | Mymd Pharmaceuticals, Inc. | NJ | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivard Paul | MD | O | GC | 2 | P | 195 | 1.11 | 0 | 175 | 78 | 400 | D | | | | | | | | | | | | | | |
8/24/23 12:00 | 8/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Michel Gaetan | NV | O | COO | 1 | P | 6 | 1.23 | 0 | 5 | 2 | 213 | D | | | | | | | | | | | | | | |
7/26/23 19:28 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fralick Celeste Rachelle | TX | D | | 1 | P | 3 | 3.98 | 0 | 1 | 7 | 12 | D | | | | | | | | | | | | | | |
7/26/23 16:28 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vos Ellen O'Connor | CT | D | | 1 | P | 15 | 3.98 | 0 | 4 | 13 | 33 | D | | | | | | | | | | | | | | |
7/25/23 17:39 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T | | 1 | P | 500 | 2.75 | 0 | 182 | 11 | 1,884 | I | | | | | | | | | | | | | | |
7/25/23 17:20 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cavanaugh Stefanie L. | TX | D | | 1 | P | 25 | 3.98 | 0 | 6 | 22 | 35 | D | | | | | | | | | | | | | | |
7/25/23 17:11 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Phan Ryan Thinh | TX | O | CSO,COO | 1 | P | 2 | 3.98 | 0 | 1 | 19 | 4 | D | | | | | | | | | | | | | | |
7/25/23 17:03 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Parnell Winfred | TX | D | | 1 | P | 25 | 3.98 | 0 | 6 | 25 | 32 | D | | | | | | | | | | | | | | |
7/25/23 16:58 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Merchant Minh Hoang | TX | O | GC,secre | 1 | P | 3 | 3.98 | 0 | 1 | 18 | 5 | M | | | | | | | | | | | | | | |
7/24/23 18:58 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jordan Veronica Gh | TX | D | | 1 | P | 15 | 3.98 | 0 | 4 | 12 | 35 | D | | | | | | | | | | | | | | |
7/24/23 18:49 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Herchuk Jannie Prestridge | TX | D | | 1 | P | 35 | 3.98 | 0 | 9 | 58 | 24 | D | | | | | | | | | | | | | | |
6/26/23 10:27 | 4/25/23 | NYMX | Nymox Pharmaceutical Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Robinson James George | MD | DT | | 2 | P.am | 55 | 0.4567 | 0 | 120 | 3 | 4,782 | D | | | | | | | | | | | | | | |
6/15/23 20:13 | 6/14/23 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Alfred D | NY | D | | 2 | P | 14 | 0.2468 | 0 | 55 | 11 | 563 | D | | | | | | | | | | | | | | |
5/31/23 17:16 | 5/26/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Davis Ted | CA | DT | | 1 | P | 6 | 3.22 | 0 | 2 | 0 | 3,576 | D | | | | | | | | | | | | | | |
5/31/23 17:16 | 5/26/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Davis Irene | CA | DT | | 1 | P | 6 | 3.22 | 0 | 2 | 0 | 3,576 | I | | | | | | | | | | | | | | |
5/26/23 12:23 | 5/24/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | 9 | P.m | 31 | 1.59 | 0 | 19 | 2 | 1,021 | D | | | | | | | | | | | | | | |
5/16/23 19:07 | 5/12/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hood Lisa | CA | O | Chief Pe | 1 | P | 5 | 1.67 | 0 | 3 | 7 | 48 | D | | | | | | | | | | | | | | |
4/7/23 17:12 | 4/5/23 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T | | 1 | P | 200 | 0.3017 | 0 | 663 | 5 | 14,829 | I | | | | | | | | | | | | | | |
1/31/23 10:06 | 1/27/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Barbieri Allen | CA | DO | Exec Vic | 1 | P | 5 | 2.94 | 0 | 2 | 2 | 101 | D | | | | | | | | | | | | | | |
1/30/23 11:36 | 1/26/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Coste Catherine | CA | DH | Audit Co | 1 | P | 6 | 2.96 | 0 | 2 | 5 | 44 | D | | | | | | | | | | | | | | |
1/9/23 16:38 | 1/6/23 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilson Kevin S. | CO | DO | CEO,P | 2 | P | 851 | 58.87 | 0 | 14 | 3 | 478 | D | | | | | | | | | | | | | | |
12/28/22 16:05 | 12/23/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Gutfreund John Peter | CA | D | | 1 | P | 25 | 0.3297 | 0 | 75 | | 75 | I | | | | | | | | | | | | | | |